Characterization of a Prospective Cohort of Women With PCOS
NCT ID: NCT02010814
Last Updated: 2023-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2012-01-01
2028-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
As part of the project, a Biobank with fasting blood samples from participants is established.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolic Disturbances in Polycystic Ovary Syndrome (PCOS)
NCT00606671
Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)
NCT02145247
DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome
NCT03911297
Glucose Metabolism and Quality of Life in Healthy Women
NCT01995773
Ovarian Contribution to Androgen Production in Adolescent Girls
NCT01421810
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PCOS
Women fulfilling at least two of the three Rotterdam criteria for PCOS, including
* Irregular menstrual cycle
* Clinical/biochemical hyperandrogenemia
* Polycystic ovaries
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marianne Andersen
DMSci
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dorte Glintborg, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Endocrinology, Odense University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Endocrinology, Odense University Hospital
Odense, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PCOS Biobank
Identifier Type: REGISTRY
Identifier Source: secondary_id
BIO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.